nach oben

Erschienen in:

04.01.2022 | COVID-19 | The Global Epidemic (S Vermund, Section Editor) Zur Zeit gratis

PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa

verfasst von: Carol W. Holtzman, Catherine Godfrey, Lawal Ismail, Elliot Raizes, Julie A. Ake, Fana Tefera, Salome Okutoyi, George K. Siberry

Erschienen in: Current HIV/AIDS Reports | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We describe the impact of COVID-19 on PEPFAR programs in Africa and how PEPFAR adapted and leveraged its interventions to the changing landscape of the COVID-19 pandemic.

Recent Findings

To mitigate the potential impact of COVID-19 on the HIV response and protect the gains, continuity of treatment was the guiding principle regarding the provision of services in PEPFAR-supported countries. As the COVID-19 pandemic matured, PEPFAR’s approach evolved from a strictly “protect and salvage” approach to a “restore and accelerate” approach that embraced innovative adaptations in service and “person-centered” care.

Summary

The impact of service delivery interruptions caused by COVID-19 on progress towards HIV epidemic control in PEPFAR-supported African countries remains undetermined. With COVID vaccine coverage many months away and more transmissible variants being reported, Africa may experience more pandemic surges. HIV programs will depend on nimble and innovative adaptations in prevention and treatment services in order to advance epidemic control objectives.

Joint United Nations Programme on HIV/AIDS. UNAIDS data 2019. Joint United Nations Programme on HIV/AIDS. 2019. https://aidsinfo.unaids.org/. Accessed 24 May 2021.

World Health Organization. WHO coronavirus (COVID-19) dashboard. World Health Organization. 2021.https://covid19.who.int/table. Accessed 24 May 2021.

U.S. President's Emergency Plan for AIDS Relief. PEPFAR technical guidance in context of COVID-19 pandemic, May 19, 2021 Update. U.S. Department of State. 2021.https://www.state.gov/wp-content/uploads/2021/05/05.19.21-PEPFAR-Technical-Guidance-During-COVID.pdf. Accessed 25 May 2021. This document provides up-to-date and comprehensive PEPFAR technical guidance on how countries should adapt services during the COVID-19 pandemic.

Davey DLJ, Bekker LG, Mashele N, Gorbach P, Coates TJ, Myer L. PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa. Lancet HIV. 2020;7(11):e735.CrossRef

J Dorward T Khubone K Gate H Ngobese Y Sookrajh S Mkhize et al 2021 The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis Lancet HIV 8 3 e158 e165. This interrupted time series analysis in South Africa showed that the 2020 national COVID-19 lockdown resulted in dramatic decreases in HIV testing and ART initiations in KwaZulu-Natal province.CrossRef

Mukwenha S, Dzinamarira T, Mugurungi O, Musuka G. Maintaining robust HIV and tuberculosis services in the COVID-19 era: a public health dilemma in Zimbabwe. Int J Infect Dis. 2020;100:394–5.CrossRef

Joint United Nations Programme on HIV/AIDS. COVID -19's HIV vertical transmission services reversed, Oct. 27, 2020. Joint United Nations Programme on HIV/AIDS. 2020. https://www.unaids.org/en/resources/presscentre/featurestories/2020/october/20201027_covid19-impact-hiv-vertical-transmission. Accessed 24 May 2021.

Stover J, Kelly SL, Mudimu E, Green D, Smith T, Taramusi I, et al. The risks and benefits of providing HIV Services during the COVID-19 pandemic. medRxiv. 2021. https://doi.org/10.1101/2021.03.01.21252663. This modeling study examined the trade-offs of COVID-related population movement restrictions and health service limitations with regards to SAR-CoV-2 and HIV mortality. Maintaining HIV services could lead to an additional 0.002 to 0.15 per 10,000 COVID-19 deaths, while limiting such services could lead to an additional 19–146 per 10,000 HIV-related deaths.

Mahwire TC, Koloane N, Burgess J, Makaba Z, Serrao C, Malone TM. Upscaling HIV pre-exposure prophylaxis implementation during COVID-19 pandemic. Conference on Retroviruses and Opportunistic Infections. June 3 - November 3, 2021. https://www.croiconference.org/abstract/upscaling-hiv-preexposure-prophylaxis-implementation-during-covid-19-pandemic/. Accessed 12 May 2021.

10.

Liu L, Christie S, Munsamy M, Roberts P, Pillay M, Shenoi SV, et al. Title: Expansion of a national differentiated service delivery model to support people living with HIV and other chronic conditions in South Africa: a descriptive analysis. BMC Health Serv Res. 2021;21(1):463.CrossRef

11.

Gross J, Hrapcak S, Rivadeneira E, Svrivastava M, Grillo M, Gurpreet K, et al. Pediatric and adolescent HIV testing and diagnosis in the context of COVID-19. Conference on Retroviruses and Opportunistic Infections. June 3 - November 3, 2021. https://www.croiconference.org/abstract/pediatric-and-adolescent-hiv-testing-and-diagnosis-in-the-context-of-covid-19/. Accessed 12 May 2021.

12.

Drammeh B, Dee A, Lasry A, Medley A, Aholou T, Yee R, et al. Changes in HIV testing services after COVID-19 in 11 sub-Saharan African countries. Conference on Retroviruses and Opportunistic Infections. June 3 - November 3, 2021. https://www.croiconference.org/abstract/changes-in-hiv-testing-services-after-covid-19-in-11-sub-saharan-african-countries/. Accessed 12 May 2021.

13.

Ortblad KF, Stekler JD. HIV self-testing: finding its way in the prevention tool box. BMC Med. 2020;18(1):373.CrossRef

14.

Bailey LS, Agaba P, Douglas M, Clinkscales J, Godfrey C. COVID-19 catalyzed expanded multi-month dispensing policies for antiretroviral therapy (ART), increasing coverage in PEPFAR-supported countries and accelerating expectations for the future of client-centered differentiated care. J Int AIDS Soc. 2021. In Press.

15.

Fatti G, Ngorima-Mabhena N, Mothibi E, Muzenda T, Choto R, Kasu T, et al. Outcomes of three- versus six-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART refill groups: a cluster-randomized trial in Zimbabwe. J Acquir Immune Defic Syndr. 2020;84(2):162–72.CrossRef

16.

Kim MH, Wanless RS, Caviness AC, Golin R, Amzel A, Ahmed S, et al. Multimonth prescription of antiretroviral therapy among children and adolescents: experiences from the Baylor International Pediatric AIDS Initiative in 6 African Countries. J Acquir Immune Defic Syndr. 2018;78(Suppl 2):S71–80.CrossRef

17.

BL Jewell E Mudimu J Stover D Brink Ten AN Phillips JA Smith et al 2020 Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models Lancet HIV 7 9 e629 e640 . This modeling study showed that a 6-month interruption in treatment across half the population of PLHIV on ART would lead to 1.63 times increase in HIV-related deaths over a 1-year period compared to no interruptions.CrossRef

18.

Fadare O, Emerenini F, Yakubu T, Dare B, Ijaiya M, Ogundare Y, et al. Sustaining early infant diagnosis of HIV during COVID-19 pandemic: experience collecting dry blood spots samples at home from HIV-exposed infants in Nigeria. Pediatr Infect Dis J. 2021;40(12):e529–30.CrossRef

19.

Odume B, Falokun V, Chukwuogo O, Ogbudebe C, Useni S, Nwokoye N, et al. Impact of COVID-19 on TB active case finding in Nigeria. Public Health Action. 2020;10(4):157–62.CrossRef

20.

Graziou P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv. 2021; https://doi.org/10.1101/2020.04.28.20079582.

21.

United Nations Children's Fund. Responding to the shadow pandemic: taking stock of gender-based violence risks and responses during COVID-19, August 20, 2020. United Nations Children's Fund. 2020. https://www.unicef.org/media/76916/file/Gender-Based-Violence-in-Emergencies-CP-Learning-Brief-Aug-2020.pdf. Accessed 27 May 2021.

22.

United Nations Children's Fund. COVID-19 - GBV risks to adolescent girls and interventions to protect and empower them. United Nations Children's Fund. 2020. https://www.unicef.org/media/68706/file/COVID-19-GBV-risks-to-adolescent-girls-and-interventions-to-protect-them-2020.pdf. Accessed 27 May 2021.

23.

United Nations Children's Fund. Getting girls back to the classroom after COVID-19 school closures. United Nations Children's Fund. 2021. https://www.unicef.org/media/94931/file/Getting%20girls%20back%20to%20the%20classroom%20after%20COVID-19%20school%20closures%20(South%20Sudan).pdf. Accessed 27 May 2021.

24.

World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020. World Health Organization. 2020. https://apps.who.int/iris/handle/10665/331501. Accessed 19 May 2021.

25.

U.S. President's Emergency Plan for AIDS Relief. PEPFAR 2021 country and regional operational plan (COP/ROP) guidance for all PEPFAR Countries. U.S. Department of State. 2021. https://www.state.gov/wp-content/uploads/2021/02/PEPFAR-COP21-Guidance-Final.pdf. Accessed 25 May 2021.

26.

Nunes MC, Baillie VL, Kwatra G, Bhikha S, Verwey C, Menezes C, et al. SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study. Clin Infect Dis. 2021.

27.

Atnafie SA, Anteneh DA, Yimenu DK, Kifle ZD. Assessment of exposure risks to COVID-19 among frontline health care workers in Amhara Region, Ethiopia: a cross-sectional survey. PLoS One. 2021;16(4):e0251000.CrossRef

28.

117th United States Congress. American rescue plan act 2021. 117th United States Congress. 2021. https://www.congress.gov/bill/117th-congress/house-bill/1319/text. Accessed 22 May 2021.

29.

U.S. President's Emergency Plan for AIDS Relief. Site improvement through monitoring systems (SIMS) Version 4.1, March 8, 2021. U.S. Department of State. 2021. https://datim.zendesk.com/hc/en-us/sections/200929305-SIMS. Accessed 25 May 2021.

30.

The Global Fund to Fight AIDS, Tuberculosis and Malaria. Global Fund thanks Germany for EUR 140 million contribution, April 8, 2021. The Global Fund to Fight AIDS, Tuberculosis and Malaria. 2021. https://www.theglobalfund.org/en/news/2021-04-08-global-fund-thanks-germany-for-eur-140-million-contribution/. Accessed 21 May 2021.

31.

The White House. Summary of the President's discretionary funding request, April 9, 2021. The White House. 2021. https://www.whitehouse.gov/wp-content/uploads/2021/04/FY2022-Discretionary-Request.pdf. Accessed 22 May 2021.

32.

Joint United Nations Programme on HIV/AIDS. COVID-19 and HIV: Progress report of 2020, Nov. 23, 2020. Joint United Nations Programme on HIV/AIDS. 2020. https://www.unaids.org/sites/default/files/media_asset/COVID-19_HIV_EN.pdf. Accessed 22 May 2021.

33.

United Nations. Policy brief: COVID-19 in an urban world, July 2020. United Nations. 2020. https://www.un.org/sites/un2.un.org/files/sg_policy_brief_covid_urban_world_july_2020.pdf. Accessed 20 May 2021.

34.

Ravelo JL. Unlocking HIV/AIDS financing during COVID-19, July 6, 2020. Devex. 2020. https://www.devex.com/news/unlocking-hiv-aids-financing-during-covid-19-97633. Accessed 20 May 2021.

35.

Jewell BL, Smith JA, Hallett TB. Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: a modelling study. EClinicalMedicine. 2020;26:100483 This modeling study showed that if VMMC and PrEP interventions cease for 3 months along with condom reductions, there would be a seven percent increase in new HIV infections..CrossRef

36.

Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, et al. Our world in data COVID-19 dataset. 2021. https://ourworldindata.org/covid-vaccinations. Accessed 24 May 2021.

Titel: PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa
verfasst von: Carol W. Holtzman
Catherine Godfrey
Lawal Ismail
Elliot Raizes
Julie A. Ake
Fana Tefera
Salome Okutoyi
George K. Siberry
Publikationsdatum: 04.01.2022
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current HIV/AIDS Reports / Ausgabe 1/2022
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-021-00587-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Social Determinants of Disease: HIV and COVID-19 Experiences

Emerging Single-cell Approaches to Understand HIV in the Central Nervous System

HIV and COVID-19 in Latin America and the Caribbean

Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update

Socioeconomic Burdens of the COVID-19 Pandemic on LMIC Populations with Increased HIV Vulnerabilities

HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development